Osterholm’s (2011) method observed the following: We searched Medline for randomised controlled trials assessing a relative reduction in influenza risk of all circulating influenza viruses during individual seasons after vaccination (efficacy) and observational studies meeting inclusion criteria (effectiveness). Eligible articles were published between Jan 1, 1967, and Feb 15, 2011, and used RT-PCR or culture for confirmation of influenza. We excluded some studies on the basis of study design and vaccine characteristics. We estimated random-effects pooled efficacy for trivalent inactivated vaccine (TIV) and live attenuated influenza vaccine (LAIV) when data were available for statistical analysis (eg, at least three studies that assessed comparable age groups) (Method, para. 2). His findings revealed that TIV; trivalent inactivated influenza vaccine (dead virus) was effective in eight of the twelve seasons, rendering 67% whereas, the LAIV; live attenuated …show more content…
The assessment reviewed mortality of nine flu seasons from 1996 to 2005 that rendered 115,823 deaths in addition to 20,484 deceased during ‘laboratory-defined flu seasons’ (Fireman, 2009). What exactly does this data present? That the widely accepted belief of the flu vaccination fails to reduce mortality rates the way in which information is portrayed. It is relevant to remain aware that the efficacy of the influenza vaccine is reliant upon a close match of the strain that is in circulation to which, LAIV is recommended for individuals between the ages of two to forty-nine and TIV for that of six months and older. Thus, regardless of what virus is in circulation and if one chooses to receive the vaccination, the recipient’s immune system response, has the final
Seasonal influenza is a major cause of mortality and morbidity in the industrialized world. The United States alone averages more than 23,000 influenza-associated deaths annually (Cortes-Penfield, 2014). Everyone is given the option to receive the flu vaccination each year. The vaccine is offered in health care facilities, clinics, and pharmacies around
To get the flu vaccine or not to get the flu vaccine? This is a huge controversial question millions of Americans today ask themselves every year. There are many myths that come along with the topic of the flu vaccine that lead to people questioning the effectiveness of the medication. Safety for our families and loved ones is what we aim to achieve, but what are the pros and cons of this vaccine? What are the consequences and what are myths, but most importantly: what are the reasons we should get it in the first place? In this paper you will learn the many reasons for the flu vaccination and how it affects different populations beginning with children all the way to the elderly population. First of all, what is the flu
The Situation/Challenge: According to the Centers for Disease Control and Prevention (CDC), the number of influenza (flu)-associated deaths in the United States ranges from a low of about 3,000 to a high of about 49,000, annually (CDC, 2010). Vulnerable populations—those with a compromised immune system, elderly, very young children, and critically ill—are especially susceptible to the influenza. (Poland, 2005). Pre-exposure vaccination is the most effective method of preventing influenza and influenza-related morbidity and mortality (Poland, 2005). However, flu vaccination is frequently contra-indicated for the vulnerable
According to the Centers for Disease Control and Prevention, “It's estimated that 90 percent of seasonal flu-related deaths and more than 60 percent of seasonal flu-related hospitalizations in the United States each year occur in people 65 years and older “ (2011).The CDC advises that the best way to prevent and control the spread of influenza each year is by the use of vaccinnations. In effort to control and prevent influenza epidemics, the CDC uses the epidemiological process to predict the strain of the virus that will be most relevant to the population and this data is used to formulate influenza vaccinations (Centers for Disease Control and Prevention, 2011).
To answer my research question I will first review literature on flu vaccines from conventional sources such as the Center for Disease Control and National Institute for Health. I will then review other material available on the Internet written by doctors that do not agree with the conventional
Every year, millions of people start talking about the influenza virus and getting their vaccines as the flu season approaches, which starts around the October-November period and reaches its peak between December and March. Therefore, public health officials around the world- and in the U.S in particular- are constantly challenged by properly preparing for the annual influenza dilemma, given that this viruses, and other respiratory viruses, are a serious health threat to the U.S population and the world as a whole. Furthermore, what makes the influenza virus even more challenging to control is that it can mutate rapidly and reassort to form new strains, having the ability to reside in multiple animal hosts. In fact, many scientists and researchers have been doing in-depth intensive research so as to understand the mechanism behind this unique characteristic of the virus, try to find new ways to control it, and explore different areas of protection and vaccination.
Influenza, an innocent little virus that annually comes and goes, has always been a part of people’s lives. Knowing this, one would not believe that it has caused not one, not two, but three pandemics and is on its way to causing a fourth! The Spanish flu of 1918, the Asian flu of 1957, and the Hong Kong
Avian influenza is a disease that has been wreaking havoc on human populations since the 16th century. With the recent outbreak in 1997 of a new H5N1 avian flu subtype, the world has begun preparing for a pandemic by looking upon its past affects. In the 20th Century, the world witnessed three pandemics in the years of 1918, 1957, and 1968. In 1918 no vaccine, antibiotic, or clear recognition of the disease was known. Killing over 40 million in less than a year, the H1N1 strain ingrained a deep and lasting fear of the virus throughout the world. Though 1957 and 1968 brought on milder pandemics, they still killed an estimated 3 million people and presented a new
Predicting vaccine efficacy of influenza vaccination is a challenge, which makes the purposes and goals of this research study focus at designing a model that will enable successful predictions of influenza vaccination’s outcomes; based on real historical medical data (Kim, & Goldie, 2008).
The efficacy of the flu vaccine has long been noted: "there is overwhelming evidence for the clinical efficacy of the influenza vaccine, especially in the elderly with chronic disease, reducing mortality and hospital admissions. There is also evidence to suggest that the influenza vaccine may be beneficial in the healthy elderly" (Morgan & King 1996: 339). Thus, there is a need to increase compliance amongst the elderly in getting a flu shot on an annual
Every fall season we hear the question; did you get your flu shot yet? It is supposed to protect you from that nasty flu virus that circulates our communities during the fall and winter months. But, did you know that in 2011 the Centers for Disease Control (CDC) Adverse Event Reporting Systems Website (AERS) reported 51 deaths caused by the flu vaccine in the United States (U.S.) (CDC,2012). According to National Vaccine Information Center (NVIC), as of July 2012 there have been more than 84,000 reports of adverse reactions, 1000 vaccine related deaths and over 1600 cases of Guillain- Barre syndrome, a acute form of paralysis, triggered by the vaccine (NVIC.ORG).
It takes about eight months for the vaccines to be developed using chicken eggs. If another pandemic were to arise, we would not have access to the vaccines for at least eight months. Moreover, once the vaccines are made, they must be used. Vaccines that are not used cannot be stored and must be destroyed because the vaccines break down. The vaccines do include the three influenza viruses; two against different strains of type A, and one against the type B virus. (Tenpenny, 2008, Davidson, 2007-2009, Offit, 2008).
Although the majority of people infected with influenza recover completely within a week to ten days, some people are at a greater risk of experiencing more severe and long-lasting complications. The flu can lead to complications such as pneumonia and in some circumstances, severe complications in high-risk groups can lead to death. The number of deaths attributed to influenza varies each year, but it is estimated to be approximately 500 to 1500 deaths per influenza season. People who are at an increased risk for complications include very young children, people over 65 years of age, and those already suffering from medical conditions including bronchitis, heart disease, diabetes, and kidney disease. Influenza vaccinations administered to high-risk people reduce hospitalizations, premature deaths, and they result in substantial cost savings to the health care system.
Each year in the United States, 3000–49,000 influenza associated deaths occur, with over 90% reported among older adults aged 65 years or older. Influenza also results in an estimated 226,000 hospitalizations, with hospitalization rates among older adults increasing over the past 2 decades (Nace et al., 2015). Influenza is a highly transmissible viral illness that may lead to severe complications from underlying diseases, primary viral or secondary bacterial pneumonia and death (NCBI, 2015). Immunization is one of the most powerful and cost effective interventions against
According to Healthy People 2020 a goal of theirs is to “increase immunization rates and reduce preventable infections.” The influenza virus is one of these preventable infections, which can cause serious harm to patients. The influenza virus is known as the “flu.” Everyone in his or her life has had some experience with the flu, whether that is himself or herself or a family member. What if there was a way to ensure people from contracting a strain of the influenza virus? Well, thanks to technology and medical research there is.